Frederic Matonti | Clinical Neuroscience | Innovative Research Award

Published on by Neuroscientists

Prof. Dr. Frederic Matonti | Clinical Neuroscience | Innovative Research Award

Prof. Dr. Frederic Matonti | Centre Monticelli Paradis | France

Frédéric Matonti is a French Professor of Ophthalmology and Universités–Praticien Hospitalier based in Marseille, currently practicing at the Centre Paradis Monticelli, where he combines advanced clinical care, surgery, teaching, and research in vision sciences. Trained through the full spectrum of medical, biological, and neuroscientific education, he holds dual doctorates in medicine and neurosciences, along with an Habilitation à Diriger des Recherches, reflecting his strong commitment to translational and academic leadership. His expertise spans refractive and cataract surgery, retinal imaging and macular diseases, glaucoma, inflammatory and infectious eye disorders, retino-vitreous surgery, and medical pedagogy, with a particular interest in the interface between ophthalmology and cognitive and integrative neuroscience. He has played a major role in training medical students, residents, and young ophthalmic surgeons while contributing to the development of innovative diagnostic and therapeutic strategies for complex ocular diseases. His scientific activity is widely recognized, with an h-index of 20, more than 162 published documents, and over 1,442 citations, highlighting the impact of his work in international literature. Through his academic, hospital, and liberal practice activities, he continues to advance patient care and research excellence in modern ophthalmology.

Citation Metrics (Scopus)

2000
1500
1000
500
0

Citations
1442

Documents
162

h-index
20

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications

Qing Ye | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Qing Ye | Clinical Neuroscience | Best Researcher Award

Dr. Qing Ye | Tianjin University Central Hospital | China

Qing Ye, MD, is a Chief Physician and Deputy Director in the Department of Digestive and Hepatology at Tianjin Third Central Hospital, where he has devoted nearly two decades to the diagnosis and management of chronic liver diseases and their complications. He earned his bachelor’s degree from Shandong Medical University, followed by a master’s degree and an MD from Tianjin Medical University, and further broadened his academic vision as a visiting scholar at Stanford University. His clinical and research interests span chronic hepatitis B, alcoholic and nonalcoholic fatty liver disease, metabolic dysfunction–associated steatotic liver disease, autoimmune liver disease, cirrhosis, ascites, portal hypertension, esophageal and gastric variceal bleeding, and liver failure. Dr. Ye has made significant contributions to understanding metabolic abnormalities in liver disease, gaps in hepatitis B care, and the global burden of lean NAFLD, with first-author publications in leading journals such as Frontiers in Immunology, Frontiers in Endocrinology, Journal of Hepatology, HepatoBiliary Surgery and Nutrition, and The Lancet Gastroenterology & Hepatology. His work has achieved wide international recognition, reflected by an h-index of 8, a total of 22 published documents, and 1,681 citations, underscoring his impact on advancing evidence-based hepatology and improving outcomes for patients with chronic liver disease.

Citation Metrics (Scopus)

2000
1500
1000
0

Citations
1,681

Documents
22

h-index
8

Citations

Documents

h-index

View Scopus Profile

Featured Publications

Basil Gruter | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Basil Gruter | Clinical Neuroscience | Research Excellence Award

Dr. Basil Gruter | Hoch Health Ostschweiz | Switzerland

Basil E. Grüter, MD, is a Swiss neurosurgeon whose clinical and academic work centers on aneurysm wall biology, cerebrovascular surgery, minimally invasive neurosurgical procedures, and the advancement of endovascular technologies. After completing his medical studies at the Universities of Fribourg and Bern, he pursued comprehensive specialty training in neurosurgery and diagnostic neuroradiology across leading Swiss institutions, including the University Hospital Zurich and Aarau Cantonal Hospital. His expertise is supported by board certification in neurosurgery, conditional eligibility in diagnostic neuroradiology, and the prestigious European Diploma in Neurointervention. Dr. Grüter’s research bridges laboratory modeling with clinical neurointervention, using animal models and intraoperative technologies to better understand vascular pathology and optimize device design. His scholarly contributions have earned substantial recognition, reflected in 845 citations from 712 documents, 65 published documents, and an h-index of 16, highlighting the growing influence of his work in the neurosurgical and neurointerventional communities. Currently serving at HOCH Health Ostschweiz and Kantonsspital St. Gallen, he remains committed to advancing patient care through innovation, interdisciplinary collaboration, and evidence-based practice. Dr. Grüter is also deeply rooted in his personal life, residing in St. Gallen with his spouse and three children while balancing family and professional responsibilities.

Profile: Scopus | Orcid

Featured Publications

  • Author, A. A., Author, B. B., Author, C. C., Author, D. D., & Author, E. E. (n.d.). Spontaneous regression of intracranial aneurysms—Case report and systematic review of the literature. Journal Name, volume(issue), pages.

  • Author, A. A., Author, B. B., Author, C. C., … Author, Z. Z. (2025). From conservative to interventional management in unruptured intracranial aneurysms. Journal of Neurosurgery, volume(issue), pages.

  • Author, A. A., Author, B. B., Author, C. C., … Author, Z. Z. (2025). Mixed-reality head-mounted display in cranial neurosurgery: A proof-of-concept study. Brain Hemorrhages, volume(issue), pages.

  • Author, A. A., Author, B. B., Author, C. C., … Author, Z. Z. (2025). The impact of body-mass-index on functional outcomes and bleeding volumes in patients suffering spontaneous intracerebral haemorrhage. Brain Hemorrhages, volume(issue), pages.

  • Author, A. A., Author, B. B., Author, C. C., … Author, Z. Z. (2024). Aneurysm healing following treatment with biodegradable embolization materials: Assessment in a rat sidewall aneurysm model. Journal of Neurointerventional Surgery, volume(issue), pages.

  • Author, A. A., Author, B. B., Author, C. C., … Author, Z. Z. (2024). Intra-aneurysmal contrast agent stasis during intraoperative digital subtraction angiography may predict long-term occlusion after clipping. Acta Neurochirurgica, volume(issue), pages.

Junliang Yuan | Clinical Neuroscience | Neuroscience Future Leader Award

Published on by Neuroscientists

Prof. Dr. Junliang Yuan | Clinical Neuroscience | Neuroscience Future Leader Award

Prof. Dr. Junliang Yuan | Peking University Sixth Hospital | China

Dr. Junliang Yuan is a neurologist, Associate Professor, and Director of the Department of Neurology at Peking University Sixth Hospital, Beijing, China. He earned his Bachelor’s degree in Clinical Medicine from Jining Medical College, a Master’s in Neurology from Dalian Medical University, and a Medical Degree in Neurology from Capital Medical University, followed by a postdoctoral fellowship at McLean Hospital/Harvard Medical School. He has also served as Associate Professor of Neurology at Beijing Chaoyang Hospital. Dr. Yuan’s research focuses on neuropsychiatric disorders, neurodegenerative diseases, cognition and dementia, movement disorders including Parkinson’s disease, and sleep disorders. He has secured multiple prestigious research grants, including funding from the Science and Technology Innovation 2030 “Brain Science and Brain-like Research” major project, the National Natural Science Foundation of China, the Chinese Academy of Sciences, and several Beijing Municipal health research programs. His scholarly output includes 91 published documents, which have been cited 1,585 times by 1,508 other publications, reflecting his influence in the field with an h-index of 22. Through his leadership and research, Dr. Yuan continues to contribute significantly to advancing clinical and translational neuroscience, with a strong focus on improving the diagnosis, management, and treatment of neurological disorders.

Profiles: Scopus | Google Scholar | Research Gate | Linked In | Staff Page

Featured Publications

Li, Y., Li, M., Zhang, X., Shi, Q., Yang, S., Fan, H., Qin, W., Yang, L., Yuan, J., Jiang, T., … (2017). Higher blood–brain barrier permeability is associated with higher white matter hyperintensities burden. Journal of Neurology, 264(7), 1474–1481.

Yuan, J., Yang, S., Wang, S., Qin, W., Yang, L., & Hu, W. (2017). Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults: A case report and literature review. BMC Neurology, 17(1), 103.

Li, Y., Li, M., Yang, L., Qin, W., Yang, S., Yuan, J., Jiang, T., & Hu, W. (2019). The relationship between blood–brain barrier permeability and enlarged perivascular spaces: A cross-sectional study. Clinical Interventions in Aging, 14, 871–878.

Chen, Y., Zhang, J., Wang, Y., Yuan, J., & Hu, W. (2016). Efficacy of cholinesterase inhibitors in vascular dementia: An updated meta-analysis. European Neurology, 75(3–4), 132–141.

Li, X., Yuan, J., Liu, L., & Hu, W. (2019). Antibody-LGI1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: A case report and literature review. BMC Neurology, 19(1), 19.

Zhang, X., Ding, L., Yang, L., Qin, W., Yuan, J., Li, S., & Hu, W. (2016). Brain atrophy correlates with severe enlarged perivascular spaces in basal ganglia among lacunar stroke patients. PLoS ONE, 11(2), e0149593.

Li, X., Yuan, J., Yang, L., Qin, W., Yang, S., Li, Y., Fan, H., & Hu, W. (2017). The significant effects of cerebral microbleeds on cognitive dysfunction: An updated meta-analysis. PLoS ONE, 12(9), e0185145.

Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Dr. Antonella Santuccione Chadha, Women` s Brain Foundation,  Switzerland.

Dr. Antonella Chadha Santuccione is a highly accomplished clinical pathologist, neuroscientist, and executive leader with notable expertise in clinical trial management and cognitive behavioral therapy. Born in Italy and based in Switzerland, she has held executive roles and board memberships across biotech and healthcare organizations. She is also the founder and pro-bono CEO of the Women’s Brain Foundation, emphasizing her commitment to neuroscience and gender-specific brain health.

Profile

Scopus
Orcid

📚 Early Academic Pursuits

Dr. Antonella Chadha Santuccione’s academic foundation is deeply rooted in medical science and behavioral therapy, reflecting her passion for understanding the human mind and body. Born on June 13, 1974, in Penne, Italy, she pursued her education in medicine, earning her MD with specialization in Clinical Pathology. Furthering her academic rigor, she attained credentials from FMH and MEBEKO and completed a CAS in Clinical Trial Management. With an eye toward holistic care and human psychology, she expanded her studies to include Cognitive Behavioral Therapy. Her diverse training laid the groundwork for a multifaceted approach to clinical neuroscience, bridging biology, diagnostics, and therapeutic psychology.

🧪 Professional Endeavors

Throughout her professional journey, Dr. Santuccione has combined her clinical acumen with entrepreneurial vision. After relocating to Switzerland, she took on advisory roles in several neuro-focused start-ups including Bottneuro, Altoida, Pipra, ReconnectLab, and EqualCare, where she played a pivotal role in aligning scientific discovery with patient-centered innovation. Serving as an Executive Director and Board Member across multiple initiatives, she brought together cross-disciplinary teams to push the frontiers of diagnostics and digital health. Her pro-bono leadership as the Founder and CEO of the Women’s Brain Foundation further demonstrates her commitment to addressing gender disparities in brain health research and care.

🧠 Contributions and Research Focus

Dr. Santuccione’s work focuses on the intersection of neuroscience, gender-specific medicine, and clinical innovation. Her research advocacy highlights the importance of considering sex differences in neurodegenerative diseases such as Alzheimer’s, a field historically underexplored. By promoting personalized approaches to brain health, she has helped shape how researchers and clinicians think about prevention, diagnosis, and treatment across genders. Her insights into cognitive decline, early diagnostic markers, and patient-centric treatment frameworks have influenced both academic thought and clinical practice. Additionally, her work in start-ups integrates AI and data-driven technologies to monitor cognitive health, marking her as a forerunner in digital neuroscience.

🏅 Accolades and Recognition

Dr. Santuccione’s contributions have earned her widespread acclaim both within Switzerland and internationally. She was selected among the Top 100 Business Women in Switzerland from 2018 to 2023, a testament to her sustained influence in science and innovation. In 2019, she was named Woman of the Year by Women in Business CH through a public election, highlighting her societal impact beyond the scientific community. The World Sustainability Award in 2020 and the Bold Women Award Switzerland in 2022 recognized her efforts in building ethical, inclusive scientific models. Most recently, she received the Empowering Women Award 2024 and was featured among the Women to Watch 2025, celebrating her as a role model for future leaders.

🌍 Impact and Influence

Beyond her clinical and scientific achievements, Dr. Santuccione has become a global advocate for change in the healthcare landscape. Her work challenges the traditional silos of medicine, psychology, and technology, offering integrative solutions that are ethical and inclusive. She has empowered countless women in STEM through her foundation, speaking engagements, and mentorship programs. Her influence extends into public policy discussions and public health awareness campaigns, where she brings attention to the need for gender equity and individualized treatment in brain disorders. She is not only a scientist but a communicator who bridges science and society.

💡 Legacy and Future Contributions

Dr. Antonella Chadha Santuccione is a trailblazer shaping the next era of neuroscience through compassion-driven research and visionary leadership. Her legacy lies in her determination to dismantle systemic barriers in medicine—especially those that affect women—and in creating frameworks where innovation serves the individual. With ongoing roles in biotech leadership, nonprofit work, and public advocacy, she is set to further influence global conversations around brain health, mental wellness, and gendered research. Her career is a beacon for aspiring researchers who believe that science should serve humanity with empathy, precision, and equity.

🧬 A Champion for Brain Science and Humanity

Dr. Santuccione embodies the rare synthesis of scientific brilliance, leadership excellence, and humanitarian vision. Her work underscores a commitment to better understanding the human brain—not only through the lens of pathology, but also through the lens of experience, gender, and empathy. As she continues her journey, she stands as a symbol of what it means to be a 21st-century neuroscientist: grounded in evidence, driven by innovation, and devoted to people.

Publication

1. Title: Women’s brain health and brain capital
Authors: Laura Castro-Aldrete, Megan Greenfield, Erin Smith, Harris A. Eyre, Mariapaola Barbato, Lucy Pérez, Antonella Santuccione Chadha
Year: 2025

2. Title: Abortion and Miscarriage on Twitter: Sentiment and Polarity Analysis from a gendered perspective
Authors: Olivier Philippe, María Flores Rodero, Claire Yohalem Furtick, Laura Planas Simón, Maria Teresa Ferretti, Antonella Santuccione Chadha, Laia Subirats Maté, Davide Cirillo, María José Rementeria
Year: 2024

3. Title: Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts
Authors: Matamoros-Angles A, Mohammadi B, Song F, Shafiq M, Brenna S, Puig B, Glatzel M, Altmeppen HC
Year: 2023

4. Title: Global synergistic actions to improve brain health for human development
Authors: Owolabi MO, Leonardi M, Bassetti C, Jaarsma J, Hawrot T, Makanjuola AI, Dhamija RK, Feng W, Straub V, Camaradou J, et al.
Year: 2023

5. Title: Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution
Authors: Laura Castro-Aldrete, Moser MV, Putignano G, Ferretti MT, Schumacher Dimech A, Antonella Santuccione Chadha
Year: 2023

6. Title: Towards AI-driven longevity research: An overview
Authors: Marino N, Putignano G, Cappilli S, Chersoni E, Antonella Santuccione Chadha, Calabrese G, Bischof E, Vanhaelen Q, Zhavoronkov A, Scarano B
Year: 2023

7. Title: Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
Authors: Pfundstein G, Nikonenko AG, Sytnyk V
Year: 2022

8. Title: Prions induce an early Arc response and a subsequent reduction in mGluR5 in the hippocampus
Authors: Ojeda-Juárez D, Lawrence JA, Soldau K, Pizzo DP, Wheeler E, Aguilar-Calvo P, Khuu H, Chen J, Malik A, Funk G, et al.
Year: 2022

9. Title: Digital biomarkers and sex impacts in Alzheimer’s disease management – potential utility for innovative 3P medicine approach
Authors: Harms RL, Ferrari A, Meier IB, Martinkova J, Santus E, Marino N, Cirillo D, Mellino S, Catuara Solarz S, Tarnanas I, et al.
Year: 2022

🏁 Conclusion

Dr. Antonella Chadha Santuccione’s career is a model of interdisciplinary excellence, innovation, and advocacy. Her ability to blend neuroscience research with executive leadership and public engagement sets her apart as a visionary in brain health. She not only advances the scientific understanding of neurodegeneration but also actively reshapes how gender and equity are addressed in medical research. With a lasting legacy in both scientific and humanitarian domains, she is exceptionally well-suited for high-level recognition such as the Best Researcher Award and remains a powerful voice shaping the future of neuroscience globally.